► 1:11 Reducing Dosage to Manage Side Effects of Long-Term TKI Use CML Content Hub @CoplandMhairi, of @UofGlasgow, discusses #management of #side effects with long-term #TKI use.
► 06:40 Successful Treatment-Free Remission in Patients With CML After TKI Discontinuation CML Content Hub @FadiHaddad_MD, of @MDAndersonNews, discusses treatment-free remission in #CML.
► 26:24 Novel Strategies for Treating Meningiomas Neurology Nancy Ann Oberheim Bush, MD, PhD, of @NeurosurgUCSF, discusses #emerging #therapy for #meningiomas.
► Physician Burnout: Addressing the Rapid Increase Business of Medicine Christine Sinsky, MD, and Todd Unger, of @AmerMedicalAssn, discuss physician #burnout.
► 7:06 Timing Discontinuation of Treatment: Critical to Maximize Chances of Successful TFR CML Content Hub @FadiHaddad_MD, of @MDAndersonNews, discusses #treatment #discontinuation in #CML.
► 0:39 Additional Chromosomal Abnormalities in CML: An Indication for Close Monitoring CML Content Hub Susanne Saussele, MD, discusses the importance of #chromosome #abnormalities in #CML.
► 0:59 FLOT2 Deficiency and Prolonged Survival in CML CML Content Hub Daniela Krause, MD, of @goetheuni, discusses #FLOT2 deficiency and #survival in #CML.
► 1:09 Selecting CML Patients Eligible for Treatment Cessation CML Content Hub Susanne Saussele, MD, discusses #treatment #discontinuation in #CML.
► 1:02 Votobatinib Promising in Phase 1/2 Trial of Mostly Heavily Pretreated CML Patients CML Content Hub @GCC_Cortes, of @GACancerCenter, discusses #votobatinib in #CML.
► 2:42 Managing Long-Term Toxicities in Pediatric CML-CP CML Content Hub Nirmalya Roy Moulik, MD, PhD, of @TataMemorial, discusses #chronic #phase #CML in #pediatric patients.